Dose-escalating study evaluating safety, PK & PD in psoriasis patients

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  228379

• Contact name

  Muna Albayaty

• Contact email

  muna.albayaty@parexel.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2017-000168-14

• Duration of Study in the UK

  0 years, 8 months, 23 days

• Research summary

  Publication of this data is currently deferred.

• REC name

  West Midlands - Coventry & Warwickshire Research Ethics Committee

• REC reference

  17/WM/0210

• Date of REC Opinion

  21 Jun 2017

• REC opinion

  Further Information Favourable Opinion